According to the latest report by IMARC Group, titled "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global dermatology diagnostic devices market reached a value of US$ 14.7 Billion in 2022. Dermatology diagnostic devices involve the use of numerous tools and machines that facilitate the early detection and identification of several skin disorders. Microscopes, cameras, dermatoscopes and imaging devices are increasingly employed for identifying numerous skin conditions, including acne, pigmentation, psoriasis, skin cancer and melanoma. These tools assist in performing a visual examination of the affected area in an attempt to diagnose the condition. They also play a pertinent role in specifying a treatment plan through microscopic observations of the concerned area of the skin.
Global Dermatology Diagnostic Devices Market Trends:
The global market is primarily driven by the increasing prevalence of dermatological conditions among the masses. This can be attributed to the rising levels of pollutants in the air, along with the changing lifestyle preferences and the shifting dietary patterns of individuals. Coupled with the escalating concerns regarding skin health, this has impelled the demand for efficient dermatology diagnostic devices across the healthcare sector. Moreover, there has been a rising preference for non-invasive aesthetic procedures among the patients, which has provided a boost to the uptake of these devices. The market is further driven by a considerable rise in the geriatric population on the global level. Since they are more prone to develop dermal disorders, including skin cancer and melanoma, this has provided a boost to the uptake of these devices for accurate diagnosis of the medical condition. Furthermore, widespread adoption of technologically advanced dermatology diagnostic devices is acting as another major growth-inducing factor. For instance, innovative devices equipped with advanced skin imaging technologies, such as polarized-light imaging, terahertz imaging, q-space trajectory imaging (QTI), and optical coherence tomography (OCT), are increasingly being adopted by healthcare professionals for better diagnosis of complicated conditions with precise results. The launch of numerous compact dermatological diagnostic devices with easy-to-use features is also providing a thrust to the market growth. On account of the aforementioned factors, the market is anticipated to exhibit a CAGR of 9.8% during 2023-2028.
- On the basis of the product type, the market has been divided into imaging devices, microscopes, immunoassays, molecular diagnostics and others. Amongst these, imaging devices represent the most preferred product type.
- Based on the end use, the market has been classified into hospitals, diagnostic labs and others. Currently, hospitals account for majority of the total global market.
- On the geographical front, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Abbott Diagnostics, Strata Skin Sciences, Michelson Diagnostics, Heine Optotechnik, Roche Diagnostics, Welch Allyn, Carl Zeiss Meditec, Nikon Corporation, Leica Microsystems GmbH, MELA Sciences, Inc., GE Healthcare Ltd., Bruker Corporation, Philips Healthcare, Siemens Healthcare Diagnostics Inc., Toshiba Medical Systems Corporation, and Photomedex, Inc.
|Base Year of the Analysis
||Product Type, End-Use, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||Abbott Diagnostics, Strata Skin Sciences, Michelson Diagnostics, Heine Optotechnik, Roche Diagnostics, Welch Allyn, Carl Zeiss Meditec, Nikon Corporation, Leica Microsystems GmbH, MELA Sciences, Inc., GE Healthcare Ltd., Bruker Corporation, Philips Healthcare, Siemens Healthcare Diagnostics Inc., Toshiba Medical Systems Corporation and Photomedex, Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal